China VC slump is set to drag Asia-Pacific fundraising down to a 10 years reduced

China VC slump is set to drag Asia-Pacific fundraising down to a 10 years reduced


Crucial Factors
  • China-focused enterprise capital funds raised $2.7 billion in the second quarter, a fall of additional than 50% from the 1st quarter, Preqin reported.
  • China-focused enterprise capital and other private financial commitment cash have viewed these a gradual start off to the year they’re envisioned to drag down Asia-Pacific fundraising to the most affordable in ten decades, the report claimed.
  • Reflecting a world-wide trend in falling valuations, China-primarily based trend startup Shein lifted $2 billion in the second quarter — but at a valuation of $66 billion vs . $100 billion just above a year back, Preqin claimed.



Resource

Here are 3 forces that drove the stock market during Wall Street’s comeback week
Finance

Here are 3 forces that drove the stock market during Wall Street’s comeback week

The stock market staged a comeback last week, even as Wall Street waded through a flurry of both upbeat and unsettling headlines. The Nasdaq broke its five-week losing streak on Friday, buoyed by strong advances from our big tech names like Meta Platforms , Nvidia and Amazon . The tech-heavy index ended the week 1.9% […]

Read More
Market volatility trap? Why this income-first strategy may ‘leave a lot on the table’
Finance

Market volatility trap? Why this income-first strategy may ‘leave a lot on the table’

ETF Edge Market volatility trap? Why this income-first strategy may ‘leave a lot on the table’ Published Sat, Feb 21 202611:00 AM EST Blair Bao WATCH LIVE Source

Read More
Stocks making the biggest moves premarket: Grail, Blue Owl Capital, Opendoor Technologies & more
Finance

Stocks making the biggest moves premarket: Grail, Blue Owl Capital, Opendoor Technologies & more

Check out the companies making headlines before the bell. Grail — Shares cratered 47% after the company said a trial of one of its drugs missed its primary endpoint and failed to show statistically significant Stage III-IV cancer reduction. Blue Owl Capital — Shares slid nearly 3%, a day after after the private market and […]

Read More